DNA damage and the balance between survival and death in cancer biology

WP Roos, AD Thomas, B Kaina - Nature Reviews Cancer, 2016 - nature.com
DNA is vulnerable to damage resulting from endogenous metabolites, environmental and
dietary carcinogens, some anti-inflammatory drugs, and genotoxic cancer therapeutics …

The DNA damage-induced cell death response: a roadmap to kill cancer cells

S Matt, TG Hofmann - Cellular and Molecular Life Sciences, 2016 - Springer
Upon massive DNA damage cells fail to undergo productive DNA repair and trigger the cell
death response. Resistance to cell death is linked to cellular transformation and …

Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death

D Vucic, VM Dixit, IE Wertz - Nature reviews Molecular cell biology, 2011 - nature.com
The proper regulation of apoptosis is essential for the survival of multicellular organisms.
Furthermore, excessive apoptosis can contribute to neurodegenerative diseases, anaemia …

DNA repair in personalized brain cancer therapy with temozolomide and nitrosoureas

B Kaina, M Christmann - DNA repair, 2019 - Elsevier
Alkylating agents have been used since the 60ties in brain cancer chemotherapy. Their
target is the DNA and, although the DNA of normal and cancer cells is damaged …

Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2

S Textor, N Fiegler, A Arnold, A Porgador, TG Hofmann… - Cancer research, 2011 - AACR
Natural killer (NK) cells are immune cells sensing and eliminating foreign, stressed,
transformed, and senescent cells through specialized surface receptors, such as NKG2D …

A systems-level study reveals regulators of membrane-less organelles in human cells

D Berchtold, N Battich, L Pelkmans - Molecular cell, 2018 - cell.com
Membrane-less organelles (MLOs) are liquid-like subcellular compartments that form
through phase separation of proteins and RNA. While their biophysical properties are …

The molecular programme of tumour reversion: the steps beyond malignant transformation

A Telerman, R Amson - Nature Reviews Cancer, 2009 - nature.com
How cells become malignant has preoccupied scientists for over a century. However, the
converse question is also valid: are tumour cells capable of reverting from their malignant …

A systems approach identifies HIPK2 as a key regulator of kidney fibrosis

Y Jin, K Ratnam, PY Chuang, Y Fan, Y Zhong, Y Dai… - Nature medicine, 2012 - nature.com
Kidney fibrosis is a common process that leads to the progression of various types of kidney
disease. We used an integrated computational and experimental systems biology approach …

Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells

R Puca, L Nardinocchi, D Givol, G D'Orazi - Oncogene, 2010 - nature.com
The p53 protein is the most studied tumor suppressor and the p53 pathway has been shown
to mediate cellular stress responses that are disrupted when cancer develops. After DNA …

GSK3β controls epithelial–mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug

SH Kao, WL Wang, CY Chen, YL Chang, YY Wu… - Oncogene, 2014 - nature.com
Glycogen synthase kinase 3 beta (GSK3β) is highly inactivated in epithelial cancers and is
known to inhibit tumor migration and invasion. The zinc-finger-containing transcriptional …